SULT1A1 and cancer: Considering our findings that SULT1A1 expression is induced by 4OH-TMX treatment (Fig. 1), and that SULT1A1 expression is required for RITA, AF, ONC-1 antitumor activity, we hypothesized that the compounds would kill TMX-pretreated cancer cells more efficiently.